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Background: Bacteria use various mechanisms to anchor their surface proteins, including a sortase enzyme.
Results: Covalent anchoring of proteins to the peptidoglycan in Clostridium difficile and its regulation by cyclic diGMP and
protease activity are demonstrated.
Conclusion: A novel regulatory mechanism of cell wall protein anchoring is found.
Significance: Elucidating how proteins are anchored may shed light on control of bacterial colonization in vivo.
InGram-positive pathogens, surface proteinsmay be covalently
anchored to the bacterial peptidoglycan by sortase, a cysteine
transpeptidase enzyme. In contrast to other Gram-positive bacte-
ria, only one single sortase enzyme, SrtB, is conserved between
strainsofClostridiumdifficile. Sortase-mediatedpeptidaseactivity
hasbeenreported invitro,andsevenpotential substrateshavebeen
identified. Here, we demonstrate the functionality of sortase in C.
difficile. We identify two sortase-anchored proteins, the putative
adhesinsCD2831 andCD3246, anddetermine the cell wall anchor
structure of CD2831. The C-terminal PPKTG sorting motif of
CD2831 is cleavedbetweenthe threonineandglycine residues, and
the carboxyl group of threonine is amide-linked to the side chain
aminogroupofdiaminopimelicacidwithin thepeptidoglycanpep-
tide stem.We show that CD2831 protein levels are elevated in the
presence of high intracellular cyclic diGMP (c-diGMP) concentra-
tions, in agreement with the control of CD2831 expression by a
c-diGMP-dependent type II riboswitch. Low c-diGMP levels
induce the release of CD2831 and presumably CD3246 from
the surface of cells. This regulation is mediated by proteolytic
cleavage of CD2831 and CD3246 by the zinc metalloprotease
ZmpI, whose expression is controlled by a type I c-diGMP ribo-
switch.Thesedata reveal anovel regulatorymechanismforexpres-
sion of two sortase substrates by the secondary messenger
c-diGMP, on which surface anchoring is dependent.
Clostridium difficile, a Gram-positive spore-forming bacte-
rium, is the major cause of intestinal disease associated with
antibiotic therapy (1). C. difficile infection is a serious risk
within health care environments but is increasingly recognized
as a community-associated disease (2, 3). Outbreaks leading to
increased morbidity and mortality have been associated with
highly virulent strains such as BI/NAP1/027 (4). C. difficile
infection can result in a spectrum of symptoms, ranging from
mild diarrhea to life-threatening pseudomembranous colitis
and colon perforation (5). The major virulence factors mediat-
ing these symptoms are the toxins (TcdA and TcdB) that alter
the actin cytoskeleton of intestinal epithelial cells through gly-
cosylation of Rho family proteins, leading to a severe inflamma-
tory response (6). Transmission of C. difficile is mediated by
spores, which persist in the environment and are difficult to
eradicate (7). C. difficile takes advantage of the disturbance of
the normal colonic microbiota following antibiotic treatment
to colonize the gastrointestinal tract (8). However, little is
known about the mechanisms of gastrointestinal colonization,
which could provide the basis to develop an effective treatment
to reduce this problematic pathogen.
Bacterial surface structures such as pili and surface proteins
can function as adhesins that enable pathogens to adhere to
sites of infection (9). In Gram-positive bacteria, these virulence
factors are often covalently attached to the peptidoglycan by a
universalmechanism requiringmembrane-associated enzymes
termed sortases (10). Based on their primary sequences, sortase
enzymes are currently grouped into six classes whosemembers
have been shown to recognize different sorting motifs and to
have distinct functions (11). The best studied is the class A
sortase (SrtA), characterized in Staphylococcus aureus and
other Gram-positive species and responsible for the anchoring
of a large number of proteins to the cell wall (12). All classes of
sortase catalyze a transpeptidation reaction involving cleavage
at a specific motif in the C-terminal sorting signal of a sortase
substrate, a surface-localized protein. In the case of class A sor-
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tases, this motif is “LPXTG,” with the exact motif varying
between classes of sortase and species.
The sorting signal encompasses the LPXTG motif followed
by a hydrophobic domain and a short positively charged tail
(10). After synthesis in the bacterial cytoplasm, sortase sub-
strate precursors are directed toward the Sec secretion system
via their N-terminal secretion signal for translocation across
the membrane. The hydrophobic domain and the positively
charged tail ensure retention of the proteins in the membrane,
allowing processing by sortase. Class A sortase cleaves the pep-
tide bond between the threonine (Thr) and the glycine (Gly)
group of the LPXTGmotif and anchor the carboxyl group thre-
onine to the peptidoglycan precursor lipid II before its incorpo-
ration to themature peptidoglycan. In contrast, class B sortases
recognize motifs with variations from the canonical LPXTG
motif, and they have been proposed to anchor their substrates
directly to the mature assembled peptidoglycan rather than to
lipid II (13, 14).
InC. difficile, only one sortase gene (CD2718) is conserved in
all sequenced strains. The sortase protein showsmost sequence
similarity to class B sortases and is annotated as SrtB (15).
Recently, a structure for SrtB was determined, which is similar
to other class B sortases (16). Bioinformatics approaches
allowed the identification of seven putative sortase substrates in
C. difficile 630, and the predicted sorting motif has been pro-
posed to be (S/P)PXTG (17–19). Recently, functionality of SrtB
has been demonstrated in vitro. Purified recombinant SrtB can
cleave short (S/P)PXTGmotif-containing peptides between the
Thr andGly residues and can covalently anchor theThr residue
to a nucleophile such as glycine or meso-diaminopimelic acid
(mDAP)5 (17, 18). Additionally cell wall anchoring of the puta-
tive sortase substrate CD0386 is dependent on the activity of
SrtB (16). However, there is no evidence that SrtB can cova-
lently anchor proteins to the peptidoglycan of C. difficile.
Here, we demonstrate two proteins, CD2831 and CD3246,
are anchored to the cell wall through sortase activity of SrtB
that catalyzes covalent attachment of substrates to the mDAP
of the peptidoglycan. CD2831 is a target for themetalloprotease
ZmpI (CD2830) that cleaves its substrate at the C terminus,
releasing it into the culture supernatantwhen levels of ZmpI are
sufficient. CD2831 and ZmpI are inversely controlled by
c-diGMP (20), and we show that increased synthesis of
c-diGMP leads to cell wall anchoring of CD2831. This work
reveals a novel association of sortase activity with c-diGMP-
mediated regulation to control levels of cell wall anchoring and
secretion of putative adhesion molecules.
Experimental Procedures
GrowthConditions—All strains used are listed in supplemen-
tal Table S1.C. difficile strains were routinely cultured on BHIS
agar (brain heart infusion agar supplemented with 0.1% L-cys-
teine and 5 mg/ml yeast extract) or BHIS broth at 37 °C in an
anaerobic environment (80%N2, 10%CO2, and 10%H2).When
necessary, C. difficile culture media were supplemented with
cycloserine (250g/ml), cefoxitin (25g/ml), or thiamphenicol
(15 g/ml). C. difficile minimal medium (21) supplemented
with 5-fluorocytosine (50 g/ml) was used to isolate double
crossovers in C. difficile. Anhydrotetracycline (ATc, 5–100
ng/ml) was used for induction of the Ptet promoter in the C.
difficile expression vectors. C. difficile strains were generally
grown to an absorbance at 600 nm (A600 nm) of 1–1.5. Unless
specified otherwise, strains carrying pRPF185 derivatives were
grown overnight in BHIS broth supplemented with 100 ng/ml
ATc and subcultured to an A600 nm of 0.1 in BHIS medium
containing 100 ng/ml ATc. Escherichia coli NEB5 (New Eng-
land Biolabs) was used for cloning and plasmid propagation.
E. coli Rosetta (Novagen) was used to carry out protein expres-
sion and E. coli CA434 (HB101 carrying R702) was used for
conjugation of plasmids intoC. difficile. E. coli strains were cul-
tured aerobically at 37 °C in LB broth or LB agar (MP Biomedi-
cals) supplemented with chloramphenicol (15 g/ml), carben-
icillin (50 g/ml), or kanamycin (50 g/ml) where appropriate.
For inducible protein expression, E. coli strains were grown in
OverNight Express Instant TB broth (Novagen) supplemented
with 10 ml/liter glycerol and the appropriate antibiotics.
Plasmid and Strain Construction—Plasmids and oligonucle-
otides are listed in supplemental Table S1 andwere constructed
using standard methods. For the expression of recombinant
catalytic domain of endolysin CD27L (22), DNA encoding res-
idues 1–179 of CD27L and an N-terminal His tag-encoding
sequence were synthesized (GeneScript) and ligated between
NdeI and XhoI sites in pET28a, yielding pHAS042.
For the expression of recombinant CD2831 (residues
32–290), primers NF1614 and NF1615 were used to PCR-am-
plify the corresponding DNA sequence. Purified PCR product
was digested with NcoI and XhoI and ligated into the pET28a
vector digested with the same enzymes, yielding pHAS027. For
the expression of recombinant SrtB, srtB flanking primers
NF1968 andNF1969 were used to PCR-amplify the srtB coding
sequence deleted in theN-terminal hydrophobic domain. Puri-
fied PCR product was digested with NcoI and XhoI and ligated
into the pET28a vector digested with the same enzymes, yield-
ing pJKP001. All pET28a-derived plasmids were initially trans-
formed into E. coli strain NEB5 (New England Biolabs), and
sequences of all inserts were verified by sequencing. Plasmids
were then transformed into E. coli strain Rosetta for protein
expression and purification.
For expression of CD2831 in C. difficile, CD2831 flanking
primers NF2501 and NF2502 were used to PCR-amplify the
CD2831 coding sequence and its preceding RBS. For the
expression of CD1420/DccA, dccA flanking primers NF2126/
NF2199 were used to PCR-amplify the dccA-coding sequence
and its preceding RBS and to add a C-terminal His tag. Purified
PCR products were digested with SacI and BamHI and ligated
into pRFP144, under control of the constitutive Pcwp2 pro-
moter, or into pRFP185, under the control of theATc-inducible
Ptet promoter (23), and digested with the same enzymes.
To introduce an arginyl-hemagglutinin (R-HA) epitope tag
into CD2831, plasmid pJKP041 (carries Ptet-CD2831 for induc-
ible CD2831 expression) was modified by inverse PCR with
oligonucleotides NF2958 andNF2959, containing an appended
sequence encoding for the arginyl-HA tag, yielding pJKP095.
5 The abbreviations used are: mDAP, meso-diaminopimelic acid; ATc, anhy-
drotetracycline; c-diGMP, cyclic diGMP; RBS, ribosome-binding site; R-HA,
arginyl-hemagglutinin.
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The arginyl-hemagglutinin tag was introduced five residues
upstream of CD2831 PPKTG-sorting motif.
For the expression of CD3246HA, CD3246-flanking primers
NF2860 and NF2861 were first used to PCR-amplify the
CD3246-coding sequence. These two primers were designed
using NEB Builder (New England Biolabs) so that DNA frag-
ments to be fused contain an overlapping sequence with adja-
cent fragments. BecauseCD3246 lacks a complete RBS, the RBS
of CD3392, another putative sortase substrate, was added
upstream from the CD3246-coding sequence. To achieve that,
theCD3392-coding sequence and it preceding RBSwere ampli-
fied by PCR with oligonucleotides NF2378 and NF2379, and
purified PCR products were digested with SacI and BamHI and
ligated into pRFP185, under the control of the ATc-inducible
Ptet promoter, and digested with the same enzymes. Inverse
PCR was then carried out on the resulting plasmid using prim-
ers NF2451 and NF2858 to delete the entire CD3392-coding
sequence but keep its RBS. Resulting plasmid was then assem-
bled with previously amplified CD3246-coding sequence using
the Gibson Assembly Master Mix (New England Biolabs).
Resulting plasmidwas thenmodified by inverse PCRwith prim-
ers pair NF2726/NF2727 to add an HA tag-encoding sequence,
yielding pJKP070. The HA tag was added five amino acids
downstream from the CD3246 signal peptide.
Plasmids for protein expression in C. difficile were initially
transformed into E. coli strain NEB5 (New England Biolabs),
and sequences of all inserts were verified by sequencing. Plas-
mids were then transformed into E. coliCA434 and transferred
by conjugation into the appropriate C. difficile strains.
The knock-out and knock-in strains generated in this study
were created using the codA-mediated allele exchange method
as described previously (24), with somemodifications. For dele-
tion of the srtB gene, a 1.85-kb DNA fragment comprising the
gene to be deleted was amplified by PCR from 630 genomic
DNAs using primers NF2155/NF2156. Purified PCR product
was digested with EcoRI and BamHI and ligated into pUC19.
Recombinant plasmid was purified and used as a template for
inverse PCR with oligonucleotides NF2157/NF2158. This step
introduced a central deletion of 586 bp for srtB gene. After
purification, PCR product was ligated, and the resulting plas-
midwas used for PCR to amplify the entire sequence,whichwas
then cloned into the PmeI site of pMTL-SC7215 vector, yield-
ing pJKP019.
To construct C. difficile Ptet-srtB with srtB genomic expres-
sion under the control of the Ptet-inducible promoter, a 693-bp
fragment upstream from the RBS of srtB and a 700-bp fragment
encompassing the first 678 bases of srtB and its preceding RBS
were amplified from 630 genomic DNAs using primers
NF2254/NF2266 and NF2258/NF2259. Another 829-bp frag-
ment comprising the entire Ptet promoter and its preceding
terminator was amplified from the pRFP185 plasmid (23) using
primers NF2257/NF2267. All these primers were designed
using NEB Builder (New England Biolabs) so that DNA frag-
ments to be fused contain overlapping sequence with adjacent
fragments. Purified PCR products were then ligated altogether
into the PmeI site of pMTL-SC7215 vector using the Gibson
Assembly Master Mix so that the Ptet promoter-encompassing
fragment was surrounded by the other PCR fragments, yielding
pJKP029.
To complement the srtBmutant, the srtB gene was restored
to its native locus insrtB.A1.8-kbDNA fragment encompass-
ing the first 664 bp of srtB and its upstream region and a 1.3-kb
DNA fragment encompassing the last 28 bp of srtB and its
downstream region were amplified from 630 genomic DNA
using primersNF2966/NF2967 andNF2968/2969. These prim-
ers were designed usingNEBBuilder (NewEngland Biolabs), so
that DNA fragments to be fused contain overlapping sequence
with adjacent fragments. Primer NF2968 also introduced a
codon substitution, so that the original TAA stop codon was
replaced with a synonymous TAG codon. Purified PCR prod-
ucts were then directly ligated into the PmeI site of pMTL-
SC7215 vector using theGibsonAssemblyMasterMix, yielding
pJKP096. This plasmid had a restored copy of the SrtB-encod-
ing gene, the silent stop codon substitutionmaking the comple-
mented strain easily distinguishable from the wild-type strain.
For deletion of the ZmpI-encoding gene,1.2-kb fragments
up- and downstream of the sequence to be altered were ampli-
fied from 630 genomic DNA using primers NF2922/NF2923
and NF2924/NF2925. These primers were designed using NEB
Builder (New England Biolabs) so that DNA fragments to be
fused contain overlapping sequences with adjacent fragments.
Purified PCR products were then directly ligated into the PmeI
site of pMTL-SC7215 vector using the Gibson Assembly Mas-
ter Mix, yielding pJKP088.
All pMTL-SC7215-derived plasmids were initially trans-
formed into E. coli strain NEB5 (New England Biolabs), and
sequences of all inserts were verified by sequencing. Plasmids
were then transformed into E. coli CA434 and transferred by
conjugation into the appropriate C. difficile strains. Transcon-
jugants were selected on BHIS supplemented with cycloserine,
cefoxitin, and thiamphenicol. A series of replica plating on thi-
amphenicol allowed faster growing single-crossover integrants
to be isolated, and their purity was confirmed by PCR. Single
crossover integrant colonies were then restreaked onto C. dif-
ficile minimal medium supplemented with fluorocytosine to
isolate double crossovers. Fluorocytosine-resistant clones were
restreaked onto BHIS supplemented with thiamphenicol to
screen for plasmid loss. Thiamphenicol-sensitive clones were
then tested by PCR for the presence of the expected deletions/
insertions. All constructs were confirmed by sequencing.
Purification of CD27L, CD2831, and SrtB and Generation of
Antibodies—Protein expression was induced in E. coli Rosetta
by overnight cultivation in OverNight Express Instant TB
medium. Recombinant proteins were purified by affinity chro-
matography in a HisTrap chelating HP column (GE Health-
care) on an AKTA liquid chromatography system (Pharmacia).
Recombinant CD27L and recombinant SrtB were purified
under native conditions, and recombinant CD2831 was puri-
fied under denaturating conditions and refolded on-column.
Purified CD2831 and SrtB proteins were injected into BALB/c
mice together with Freund’s incomplete adjuvant to raise poly-
clonal antibodies.
Cell Lysis, Fractionation, and Protein Analysis—Whole cell
lysates were prepared as described previously (23). Briefly, cul-
tures ofC. difficilewere harvested by centrifugation at 5000 g
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for 10 min at 4 °C, and the pellets were frozen at 20 °C. Bac-
teria were thawed, resuspended in PBS containing 0.12 g/ml
DNase I to an A600 nm of 20, and incubated at 37 °C for 40 min.
Culture supernatants were filtered with a 0.22-m filter and
precipitated on ice with 10%TCA for 30min. Suspensions were
harvested at 25,000  g for 10 min at 4 °C, and the pellet was
resuspended twice in ice-cold 90% acetone at 4 °C for 10 min.
Finally, it was resuspended in PBS to an A600 nm of 20. For cell
fractionation, cultures of C. difficile were harvested by centrif-
ugation at 5000  g for 10 min at 4 °C and resuspended in
phosphate/sucrose buffer (0.05 M HNa2PO4, pH 7.0, 0.5 M
sucrose) to an A600 nm of 20. Purified catalytic domain of endo-
lysin CD27L was added to cell suspensions at 30 g/ml, and
sampleswere incubated at 37 °C for 1 h. Protoplastswere recov-
ered by centrifugation at 6000 g for 20min at 4 °C. The super-
natant corresponded to the cell wall (CW) fraction and the pel-
let to the protoplasts. Protoplasts were resuspended in
phosphate buffer (0.05 M HNa2PO4, pH 7.0) containing 0.12
g/ml DNase I at anA600 nm of 20 and incubated at 37 °C for 45
min. Suspensions were harvested at 25,000  g for 10 min at
4 °C to separate membrane and cytoplasm fractions. Mem-
branes were finally resuspended in phosphate buffer at an
A600 nm of 20. For analysis by SDS-PAGE, an equal volume of
2 SDS sample buffer (25) was added to protein samples. SDS-
PAGE and Western immunoblotting were carried out using
standard methods.
Immunofluorescence Microscopy—C. difficile cells from liq-
uid culture were washed with PBS and fixed in 8% formalde-
hyde in PBS, which was quenched using 20 mM NH4Cl for 15
min. The washed cell suspension was spotted onto a glass slide
and allowed to dry. The bacteria were then incubated with
1:500mouse anti-CD2831 and 1:500 rabbit anti-LMW-SLP and
then washed and incubated with 1:200 anti-mouse rhodamine
red and 1:200 anti-rabbit Cy2 (Jackson ImmunoResearch,West
Grove, PA). Immunolabeled bacteria were visualized and pho-
tographed using a Nikon Eclipse E600 microscope fitted with a
Retiga2000R Fast 1394 camera.
Purification of Cell Wall-anchored CD2831R-HA—C. difficile
630zmpIharboring pJKP095was grown to anA600 nm of 1.2 in
1 liter of BHIS liquid medium in the presence of the inducer
ATc (100 ng/ml). Cells were harvested by centrifugation at
5000  g for 10 min at 4 °C and resuspended in phosphate/
sucrose buffer to an A600 nm of 40. Purified catalytic domain of
endolysin CD27L was added to the cell suspension at 30g/ml,
and the sample was incubated at 37 °C for 1 h. Protoplasts were
pelleted by centrifugation at 6000 g for 20min at 4 °C, and the
supernatant containing the digested cell wall was collected. Cell
wall extracts were concentrated using centrifugal filters (Ami-
con, Millipore) and resuspended twice in 15 ml of TBS buffer
(50 mM Tris-Cl, pH 7.6, 150 mM NaCl). Cell wall extract was
then concentrated to a final volume of 400 l, and 80 l of
Pierce anti-HA-agarose (Thermo Fisher) slurry was added.
After an overnight incubation at 4 °C with gentle shaking, resin
was pelleted by centrifugation at 12,000  g for 10 s, washed
three times with TBS supplemented with 0.05% Tween 20, and
then twice more with TBS. Cell wall-anchored CD2831R-HA
was eluted by addition of 50 mMNaOH to the resin. The eluate
was collected by centrifugation at 12,000  g for 10 s and was
neutralized with 1 M Tris-HCl, pH 2.0.
Purification of Cell Wall-anchored C-terminal CD2831R-HA
Peptide—Fifty l of purified CD2831R-HA were digested with 1
g of endoproteinase Arg-C (Roche Applied Science), accord-
ing to the manufacturer’s instructions. Arg-C cleaves at the C
terminus of arginine residues. Cleaved peptides were then
diluted in TBS, and the cell wall-anchored C-terminal
CD2831R-HA peptide was purified by immunoprecipitation
using Pierce Anti-HA-agarose as above.
Peptide Identification by Liquid Chromatography-tandem
Mass Spectrometry—The LC-MS/MS analysis was on an Ulti-
mate 3000 RSLCnano System (Dionex) coupled to an LTQ
OrbitrapVelos (Thermo Fisher) hybrid mass spectrometer
equipped with a nanospray source. The peptides were first
loaded anddesalted on a PepMapC18 trap (0.1mm inner diam-
eter 20 mm, 5 m, Dionex) and then separated on a PepMap
75 m inner diameter 50 cm column with 3 m particle size
(Dionex) over a 60-min linear gradient of 4–36% CH3CN, 0.1%
formic acid. The mass spectrometer was operated in the “top
10” data-dependent acquisitionmode. TheMS full scan was set
at m/z 380–1600 with the resolution at 30,000 at m/z 400 and
automatic gain control at 1  106 with a maximum injection
time at 200 ms. The 10 most abundant multiply charged pre-
cursor ions, with a minimal signal above 1000 counts, were
dynamically selected for collision-induced dissociation frag-
mentation (MS/MS) in the linear trap quadrupole ion trap,
which has the automatic gain control set at 5  103 with the
maximum injection time at 100 ms.
Measurement of Intracellular c-diGMP Levels—C. difficile
strains were grown in 25 ml of BHIS containing thiamphenicol
to an A600 nm of 1.0. A 10-ml culture aliquot was harvested by
centrifugation at 5000  g for 10 min at 4 °C, washed, and
freeze-dried to determine the dryweight for normalization pur-
poses. Another 10-ml aliquot from the same culture was
removed, and bacteria were collected by centrifugation at
5000  g for 10 min at 4 °C. Nucleotides were extracted from
the pellet with methanol/acetonitrile/milli-Q water (40:40:20)
as described previously (26). The c-diGMP was detected and
quantified by LC-MS/MS (26). The average intracellular con-
centration was determined by normalizing the c-diGMP mea-
surements to the bacterial dry weight.
Sporulation Assay—Overnight cultures of C. difficile grown
in BHIS medium supplemented with thiamphenicol and ATc,
when suitable, were used to inoculate 10 ml of BHIS medium
containing thiamphenicol. When necessary, ATc (100 ng/ml)
was added every 24 h to maintain the protein induction. After
24 and 72 h of growth, 1 ml of culture was divided into two
samples. To determine the total number of cfu, the first sample
was serially diluted and plated on BHIS medium plus 0.1% tau-
rocholate (Sigma). To determine the number of spores, the veg-
etative cells of the second sample were heat-killed by incuba-
tion for 25 min at 65 °C prior to plating on BHIS medium plus
0.1% taurocholate. The number of spores was subtracted from
the total cell counts to give the vegetative cell numbers.
Aggregation Assay—Assessment of aggregation was per-
formed as described previously with some modifications (27).
Briefly, overnight cultures ofC. difficile grown in BHISmedium
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supplemented with thiamphenicol and ATc, where appropri-
ate, were used to inoculate 10 ml of fresh medium. After 8 h of
growth, aggregates had settled to the bottom of the tube, and
the suspension was mostly composed of free cells. Turbidity
was measured at A600 nm from the suspension of the unper-
turbed cultures. The cultures were then dispersed by vigorous
vortexing, and the total turbidity was measured.
Results
Expression and Subcellular Localization of SrtB within C. dif-
ficile 630—Expression levels of SrtB in C. difficile 630 were too
low to detect efficiently by immunoblotting of whole cell
extracts (Fig. 1A). We therefore used allele exchange to insert
the inducible Ptet promoter and its regulatory element into the
chromosome between the native srtB promoter and the srtB
gene, leading to the Ptet-srtB strain. SrtB was detectable in
whole cell extracts of the Ptet-srtB strain with 100 or 500 ng/ml
inducer ATc (Fig. 1A). No band was observed without induc-
tion of SrtB expression. The distribution of SrtB within cytoso-
lic, membrane, and cell wall (peptidoglycan) fractions in the
Ptet-srtB strain induced with 100 ng/ml ATc was studied. As
expected, SrtBwasmainly found located in themembrane frac-
tion (Fig. 1B).
CD2831 Is a Surface-exposed Protein Released by the ZmpI
Protease—Seven putative sortase substrates have been identi-
fied in C. difficile 630, but only four are conserved in the
ribotype 027 strain R20291 (17). Their putative functions are as
follows: CD0183 and CD2768, cell wall hydrolases; CD2537, a
5-nucleotidase/phosphoesterase; and CD2831, a collagen-
binding protein. CD2831 contains two collagen-binding
domains and a CnaB-like domain (Fig. 2A). CnaB domains, first
identified in S. aureus (28), are commonly found in cell-surface
adhesins and are thought to form a stalk presenting the ligand-
binding domain away from the bacterial cell surface (29).
CD2831 is efficiently cleaved in vitro by the secreted zinc met-
alloprotease ZmpI (CD2830) (30, 31). Six different ZmpI target
cleavage sites have been identified within the C terminus of
CD2831 (Fig. 2A) and a proteomic analysis of the extracellular
medium of C. difficile cultures revealed that CD2831 is at least
partly secreted (30). To give further insight into the cellular
localization of CD2831, immunoblotting was used to localize
the protein in cellular fractions and culture supernatants of
several strains. CD2831 was poorly detected in both the super-
natant and inwhole cell lysate of strain 630 (Fig. 2B and data not
shown), suggesting that the normal levels of CD2831 are low.
Therefore, the CD2831 gene was cloned under control of the
inducible Ptet promoter on a plasmid, yielding pJKP041. Strain
630 (pJKP041) was grown in the presence of inducer, and the
distribution of CD2831 in supernatant, cell wall, membrane,
and cytoplasmic fractions was investigated. Two polypeptides
were detected byWestern blotting, observed mainly in the cul-
ture supernatant (Fig. 2B). Because SrtB expression was unde-
tectable in the wild-type 630 strain, secretion of the putative
sortase substrate CD2831 into the culture supernatant could be
due to the absence of sortase, leading to the inability to anchor
CD2831 to the cell surface. Therefore, pJKP041was introduced
into the Ptet-srtB strain, and the resultant strain was grown in
the presence of inducer. However, the subcellular distribution
of CD2831 remained unchanged in this strain (Fig. 2B), dem-
onstrating that the secretion of CD2831 into the culture super-
natant is independent of SrtB.
To investigate whether the secretion of CD2831 is a result of
its cleavage by the ZmpI protease, a zmpI deletion mutant was
generated in strain 630. pJKP041 was then introduced in this
strain, and subcellular localization of CD2831 in cells grown in
the presence of inducer was investigated. Although a small por-
tion of CD2831 was detected in the supernatant fraction, the
majority of CD2831 was localized in the cell wall fraction (Fig.
FIGURE 1.Detection and localization of SrtB. A, immunoblotting with anti-
SrtB detected a major polypeptide of 25 kDa in whole cell extracts of the
Ptet-srtB strain grown in the presence of the inducer ATc (100 and 500 ng/ml)
but not in extracts of wild-type strain 630 (WT) or not-induced Ptet-srtB strain
(0ng/mlATc).B, Ptet-srtB culture inducedwith100ng/mlATcwas fractionated
into cell wall (CW), membrane (Mb), and cytosolic (Cy) compartments and
immunoblotted with anti-SrtB polyclonal antibodies. Proteins were sepa-
rated on 12% SDS-polyacrylamide gels.
FIGURE 2.ZmpI-mediated release of the cellwall-associatedCD2831pro-
tein into the culture supernatant. A, schematic representation of CD2831.
The relevant characteristics are a signal peptide (SP), two putative collagen-
bindingdomains (CBD), a CnaB-likedomain, andaC-terminal putative sorting
signal comprising a PPKTG sortingmotif, a hydrophobic domain (ingray), and
a positively charged tail (). AA, amino acids. B, supernatant (Sn), cell wall
(CW), membrane (Mb), and cytosolic (Cy) compartment of wild type (WT),
Ptet-srtB (overexpresses the sortase in the presence of ATc), and zmpImutant
(zmpI) strains, carrying pJKP041 (expresses CD2831 in the presence of ATc)
and cultivated in the presence of 100 ng/ml ATc (ATc), were analyzed by
Western blotting with anti-CD2831 polyclonal antibodies. Supernatant and
whole cell lysate (WL) fractions of zmpI pJKP041 strain cultivated in the
absence of ATc (ATc) were also analyzed as negative controls.
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2B). Interestingly, a clear difference was observed in themolec-
ular weights of CD2831 depending on the production of the
ZmpI protease. In thewild-type strainwhereZmpI is produced,
CD2831migrates as twomajor polypeptides with sizes of120
and 130 kDa. In contrast, polypeptides detected in the zmpI
strain migrate at larger masses, between 140 and 155 kDa. This
is consistent with CD2831 being a substrate for the proteolytic
activity of ZmpI. These data indicate that CD2831 can be asso-
ciated with the cell wall and that ZmpI-mediated cleavage is
essential for complete release of CD2831 from the cell surface.
To assess CD2831 localization at the individual cell level,
immunofluorescence microscopy analysis was performed on
intact bacteria. All bacteria were uniformly labeled with anti-
LMW SLP, which detects the S-layer that completely coats C.
difficile (Fig. 3). CD2831 could be detected at the surface of the
induced zmpI pJKP041 strain (Fig. 3), but the intensity of
labeling by the anti-CD2831 antibodies appeared to be hetero-
geneous in the bacterial population. Interestingly, CD2831
labeling was not distributed along the entire bacterial cell but
was concentrated mostly at one cell pole. Similar features have
been previously reported for SrtB substrates in Listeria mono-
cytogenes (see below) (32). Most cells from the induced wild-
type pJKP041 culture were not stained with anti-CD2831, with
the exception of polar staining in a few cells. This residual fluo-
rescence was not observed in the uninduced zmpI pJKP041
strain, indicating that a small fraction of CD2831 remains at the
cell surface in the induced wild-type pJKP041 strain. It is likely
that the level of ZmpI in the extracellularmedium is insufficient
to cleave efficiently the large amount of CD2831 protein pro-
duced under inducing conditions.
SrtB Anchors CD2831 to the Cell Wall—The ZmpI cleavage
sites within CD2831 are not randomly distributed along the
protein sequence but are confined in the C-terminal extremity,
directly upstream of the putative PPKTG sorting motif (30).
Thus, it is possible that the CD2831 protein is anchored to the
cell wall through a sorting reaction catalyzed by SrtB and sub-
sequently secreted into the extracellularmedium after its cleav-
age by the ZmpI protease. To test this hypothesis, the srtB gene
in the zmpI mutant strain was inactivated by deletion.
pJKP041 was then introduced into the zmpIsrtB double
mutant, and the subcellular localization of CD2831 in this
strain grown in the presence of inducer was then analyzed by
immunoblotting and immunofluorescence microscopy. Cell
wall extracts from thezmpIsrtBmutant displayed undetect-
able levels of CD2831, whereas the protein was strongly
detected in the supernatant fraction (Fig. 4). In agreement with
these data, the anti-CD2831 antibodies did not surface-label
thezmpIsrtBmutant strain (Fig. 3), demonstrating that SrtB
is required for anchoring of CD2831 to the cell wall.
Cell Wall Anchor Structure of Endolysin-solubilized
CD2831R-HA Tag—SrtB-dependent cell wall anchoring of
CD2831 suggests its covalent anchoring to the peptidoglycan.
To determine the cell wall anchor structure of CD2831, a C-ter-
minally modified derivative (CD2831R-HA) was constructed
FIGURE 3. Display of CD2831 on the clostridial cell surface. The wild-type (WT), zmpI mutant (zmpI), and srtB/zmpI double mutant (srtBzmpI) strains
carrying pJKP041 (overexpresses CD2831 in the presence of ATc) were grown in BHIS broth in the presence of 100 ng/ml ATc (ATc) and labeled with rabbit
anti-LMW-SlpA (green, left panels) to label the surfaceof all bacteria andmouseanti-CD2831 (red,middle panels) to assessCD2831 localization.Overlays of those
images are also showed (merge, right panels). Labelingwas visualized using Cy2 anti-rabbit conjugate and rhodamine red-X anti-mouse conjugate. ThezmpI
strain carrying pJKP041 and grown in the absence of the inducer (ATc) was used as a negative control.White bars represent 10 m.
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and placed under the control of the inducible Ptet promoter
(pJKP095). CD2831R-HA consists of CD2831 with an arginine
residue and anHA tag inserted five amino acids upstreamof the
PPKTG sorting motif (Fig. 5A). pJKP095 was transferred into
thezmpImutant, and upon induction with ATc, CD2831R-HA
could be detected in both the supernatant and the cell wall
fraction by immunoblottingwith anti-CD2831 or anti-HAanti-
bodies, indicating that the subcellular localization of
CD2831R-HA is similar to that of CD2831 (data not shown).
The cell wall fraction of C. difficile expressing CD2831R-HA
was solubilized by digestion with CD27L, a C. difficile phage-
endolysin predicted to have N-acetylmuramoyl-L-amidase
activity (Fig. 5B) (22, 33). Cell wall-anchored CD2831R-HA was
then purified from this digest by immunoprecipitation with an
anti-HA affinity resin (Fig. 5C). The enriched protein was sub-
jected to digestion with the endopeptidase Arg-C, which
cleaves at the C terminus of arginine residues, and C-terminal
peptides harboring the HA tag were purified again by immuno-
precipitation. The structures of the resulting eluted peptides,
expected to be covalently anchored to peptidoglycan peptide
side chains, were then analyzed by a combination of LC-MS and
MS/MS. All peptides corresponding to CD2831 eluted as a sin-
gle wide peak (Fig. 6A). The seven prominent ions contained in
this peak were assigned based on their mass determination to
structures in agreement with an HA-tagged C-terminal
CD2831 peptide that terminates at the threonine residue of the
PPKTG sorting motif and is covalently linked to the peptide
side chain of peptidoglycan (Fig. 6, B and C). Among the differ-
ent ion signals observed, the predominant ion at m/z 802.06
with z  3 and the minor ion at m/z 1202.59 with z  2 are
proposed to have identical structures, consisting of the anchor
peptide linked to cell wall tripeptide (D-Glu-(YPYDVPDY-
AVNPPVPPKT-)mDAP-D-Ala). Both ions were subjected to
MS/MS analysis, and the main daughter ions were assigned to
the corresponding peptide structure (Figs. 6D and 7A and
Tables 1 and 2). In both cases, the fragmentation pattern was
consistentwith the predicted structure and thus confirmed that
CD2831 is covalently anchored to the peptidoglycan. The ala-
nine residue in the cell wall tripeptide was unambiguously
found to be located at theC terminus of the peptide chain of the
peptidoglycan rather than at its N terminus. Indeed, fragmen-
tation of the parental ion at m/z 802.06 (z  3) led to the gen-
eration of several daughter ions lacking the glutamate residue
but not the alanine residue (fragments with anm/z 489.86, z
2;m/z 685.26, z 1;m/z 759.11, z 1;m/z 881.40, z 1; and
m/z 978.39, z 1) and to the generation of a daughter ion atm/z
772.43 (z  3) corresponding to the loss of an alanine residue
(89.05 Da) from the C-terminal end of the peptide stem.
Moreover, because either the glutamate or alanine residue
could be individually lost, this result strongly suggests that the
anchor peptide is linked to the mDAP residue of the peptide
side chain of peptidoglycan. The minor ion atm/z 808.05 (z
3) had a 17.95- Damass difference compared with the predom-
inant ion signal, suggesting the addition of a water molecule
(Fig. 6,B andC).MS/MS fragmentation of this ion revealed that
this additional mass could be easily lost as most of the daughter
ions presented two different forms, with orwithout the extra 18
Da. Moreover, this mass could be lost either from the N-termi-
nal extremity of the anchor peptide or from the peptidoglycan
peptide stem (Fig. 7B and Table 3). Therefore, the ion at m/z
808.05 (z 3) corresponds to theHH2Oadduct of themain
structure identified above.
FIGURE 4. Role of SrtB in anchoring CD2831 to the cell wall. Supernatant
(Sn), cell wall (CW), membrane (Mb), and cytosolic (Cy) compartment of zmpI
mutant (zmpI) and srtB/zmpI double mutant (srtBzmpI) strains, carrying
pJKP041 (expresses CD2831 in the presence of ATc) and cultivated in the
presence of 100 ng/ml ATc (ATc) were analyzed by Western blotting with
anti-CD2831 polyclonal antibodies. Supernatant and whole cell lysate (WL)
fractions of zmpI pJKP041 strain cultivated in the absence of ATc (ATc)
were also analyzed as negative controls.
FIGURE 5. Expression andpurification of CD2831R-HA from the cell wall of
C. difficile zmpI. A, CD2831R-HA construct under control of the inducible
tetracycline promoter (Ptet) containing signal peptide (SP), the PPKTG motif,
the hydrophobic domain (in gray), and the positively charged tail (). Cleav-
age sites of SrtB and ArgC are indicated. B, CD2831 is covalently linked to the
peptidoglycan of C. difficile. Nonacetylated glucosamine residues (G) and
unusual mDAP-mDAP cross-links generated by DL-transpeptidation are pre-
dominant in the peptidoglycan of C. difficile (34). Cleavage sites of the CD27L
endolysin are indicated by arrowheads. NAM, N-acetylmuramic acid; DAP,
diaminopimelic acid. C, cells from zmpI strain expressing CD2831R-HA were
suspended in PS buffer and treated with the purified catalytic domain of the
CD27L endolysin. Digested cell wall was isolated by centrifugation and sub-
jected to immunoprecipitation using anti-HA. Purified polypeptides were
separated on 10% SDS-polyacrylamide gels and Coomassie Blue-stained (left
panel) or probed with anti-HA antibodies (right panel).
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Theminor ion signal atm/z 778.38with z 3 had a 70.99-Da
mass difference compared with the predominant ion signal,
indicating the lack of an alanine residue (Fig. 6,B andC). There-
fore, the corresponding structure was deduced to be D-Glu-
(YPYDVPDYAVNPPVPPKT-)mDAP, whichwas confirmed by
MS/MS analysis. This MS/MS fragmentation generated an ion
fragment with an m/z 614.21 (z  1), corresponding to the
C-terminal PPKT anchor peptide linked to the mDAP of the
peptidoglycan peptide stem (Fig. 7C and Table 4). This result
confirms that the carboxyl group of threonine is linked to the
free amino group of the mDAP of the peptidoglycan peptide
side chain.
The signal atm/z 797.39 (z 3) had a 14-Damass difference
compared with the predominant ion (Fig. 6B), and MS/MS
fragmentation of this ion showed that the C-terminal D-Ala of
the cell wall peptide had been replaced by a glycine (Fig. 7D and
Table 5). This feature is in agreement with the established
structure of cell wall peptidoglycan of vegetative C. difficile
cells, as a small proportion of muropeptides harboring glycine
at position 4 of the peptide stem instead of D-alanine was
reported (34).
The minor ion signals atm/z 677.08 (z 4) and 902.44 (z
3) had an extra mass of 301.14 Da compared with the predom-
inant ion, which matched with the addition of the dipeptide
side chain D-Glu-mDAP (Fig. 6,B andC). To examine the valid-
ity of our prediction, the parental ion atm/z 902.44 (z 3) was
fragmented by MS/MS (Fig. 7E). The fragmentation pattern
was consistent with a peptidoglycan peptide dimer consisting
of the cell wall tripeptide D-Glu-mDAP-D-Ala cross-linked to
the cell wall dipeptide D-Glu-mDAP that is branched to the
C-terminal end of CD2831R-HA peptide (Table 6). Further-
more, MS/MS analysis revealed a mDAP-mDAP cross-link
generated by DL-transpeptidation because the daughter ion at
m/z 873.04 (z  3) corresponded to the loss of one alanine
residue (89.05) from the C-terminal end of the peptide stem.
This feature is in complete agreement with the structure of the
peptidoglycan of C. difficile as 75% of the cross-links have
been shown to be generated by DL-transpeptidation (34).
Because the peptidoglycan hydrolase used in this study is
predicted to have N-acetylmuramoyl-L-amidase activity, the
expected cleavage was between the muramic acid of the glycan
chain and the L-alanine residue of the peptide chain stem. Thus,
we expected to find an alanine residue at the N-terminal
extremity of the generated peptidoglycan peptides. Yet, gluta-
mate was found to be the N-terminal amino acid of the cell wall
peptide side chain in all the elucidated structures. However, in
our study the cell wall digestion was performed on intact bac-
teria rather than purified peptidoglycan. Thus, cleavage of the
L-Ala-D-Glu cell wall peptide may be a feature of C. difficile
endogenous peptidoglycan hydrolases able to digest pepti-
doglycan after its primary cleavage by the putative amidase. An
alternative explanation could be related to the catalytic speci-
FIGURE 6. Structure of CD27L-released CD2831R-HA anchor peptides.
Reverse phase-HPLC elution profile (A) and mass spectrometry spectrum (B)
of CD2831R-HA anchor peptides. Purified CD2831R-HA was cleaved with Arg-C
togenerateC-terminal CD2831R-HA anchor peptides,whichwere further puri-
fied by a second roundof anti-HA immunoprecipitation. Purified anchor pep-
tideswere analyzed by LC-MS. C,deduced structures and their calculatedm/z
value for the different species detected by mass spectrometry. D, MS/MS
sequencing of the predominant ion at m/z 802.06 with z 3. Inferred struc-
ture is represented. The indicatedm/z values on the presented structure cor-
respond to ions obtained by cleavage of one amide bond.
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ficity of CD27L. Specificity of this endolysin has been deduced
from its crystal structure and sequence comparisons, but there
is no experimental evidence on its specificity (22). Therefore,
CD27L might be an endopeptidase cleaving between L-alanine
and D-glutamine residues.
These results demonstrate unambiguously that anchoring of
CD2831 to the cell surface requires the cleavage of the polypep-
tide chain between the threonine and glycine residues of the
predicted PPKTG-sorting motif by SrtB and that the resulting
C-terminal threonine residue is then covalently anchored to the
side chain amino group of mDAP, the third amino acid of the
peptidoglycan peptide stem.
Expression and Secretion of CD2831 Are Controlled by
c-diGMP Levels—Transcription of CD2831 is controlled by a
type II c-diGMP riboswitch (Cdi2_3) and is increased in the
presence of high levels of c-diGMP (20). Interestingly, expres-
sion of the adjacent gene CD2830 encoding ZmpI protease is
negatively regulated by c-diGMP through a type I riboswitch
(Cdi1_12) (20). Because zmpI and CD2831 are inversely regu-
lated by c-diGMP, we investigated whether CD2831 is
anchored to the cell surface in the presence of high levels of
c-diGMP. The dccA gene encoding a c-diGMP synthetase was
cloned in a plasmid under the control of the constitutive Pcwp2
promoter, leading to pECC12. Measurement of the intracellu-
FIGURE 7. MS/MS sequencing of the different ions corresponding to the CD2831R-HA anchor peptides and identified by LC-MS in Fig. 6B. MS/MS
sequencing of the ions atm/z 1202.59 with z 2 (A),m/z 808.05 with z 3 (B),m/z 778.38 with z 3 (C),m/z 797.39 with z 3 (D), andm/z 902.44 with z 3
(E).
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TABLE 1
Proposed structures of fragment ions fromMS/MS collision-induced dissociation of parental ion atm/z 802.06 (z 3)
See Fig. 6D.
Ion formed
m/z
Proposed structureCalculated Observed
[M 2H]2 489.80 489.86 (PPVPPKT-)mDAP-D-Ala
[M 2H]2 554.36 554.38 D-Glu- (PPVPPKT-)mDAP-D-Ala
[M H] 638.28 638.17 YPYDV
[M H] 685.41 685.26 (PPKT-)mDAP-D-Ala
[M 3H]3 759.05 759.11 mDAP- (YPYDVPDYAVNPPVPPKT-)D-Ala
[M 3H]3 772.38 772.43 D-Glu- (YPYDVPDYAVNPPVPPKT-)mDAP
[M H] 814.45 814.33 D-Glu- (PPKT-)mDAP-D-Ala
[M H] 850.36 850.28 YPYDVPD
[M H] 881.53 881.40 (PVPPKT-)mDAP-D-Ala
[M H] 978.58 978.39 (PPVPPKT-)mDAP-D-Ala
[M H] 1010.57 1010.37 D-Glu- (PVPPKT-)mDAP-D-Ala
[M H] 1013.43 1013.33 YPYDVPDY
[M H] 1084.46 1084.29 YPYDVPDYA
[M H] 1107.62 1107.34 D-Glu- (PPVPPKT-)mDAP-D-Ala
[M H] 1183.53 1183.22 YPYDVPDYAV
[M H] 1279.67 1279.41 DYAVNPPVPPKT
[M H] 1297.57 1297.31 YPYDVPDYAVN
[M H] 1590.75 1590.48 YPYDVPDYAVNPPV
TABLE 2
Proposed structures of fragment ions fromMS/MS collision-induced dissociation of parental ion atm/z 1202.59 (z 2)
See Fig. 7A.
Ion formed
m/z
Proposed structureCalculated Observed
[M H] 539.21 539.12 YPYD
[M H] 638.28 638.21 YPYDV
[M H] 685.41 685.24 (PPKT-)mDAP-D-Ala
[M H] 796.44 796.21 D-Glu- (PPKT-)mDAP-D-AlaH2O
[M H] 814.45 814.23 d-Glu- (PPKT-)mDAP-D-Ala
[M H] 978.58 978.31 (PPVPPKT-)mDAP-D-Ala
[M H] 1089.61 1089.43 D-Glu- (PPVPPKT-)mDAP-D-AlaH2O
[M H] 1107.62 1107.40 D-Glu- (PPVPPKT-)mDAP-D-Ala
[M 2H]2 1138.08 1138.21 (YPYDVPDYAVNPPVPPKT-)mDAP-D-Ala
[M 2H]2 1158.07 1158.17 D-Glu- (YPYDVPDYAVNPPVPPKT-)mDAP
[M H] 1221.67 1221.34 D-Glu- (NPPVPPKT-)mDAP-D-Ala
[M H] 1297.57 1297.22 YPYDVPDYAVN
[M H] 1391.77 1391.46 D-Glu- (AVNPPVPPKT-)mDAP-D-Ala
[M H] 1590.75 1590.34 YPYDVPDYAVNPPV
[M H] 1637.87 1637.49 (PDYAVNPPVPPKT-)mDAP-D-Ala
[M H] 1766.92 1766.70 D-Glu- (PDYAVNPPVPPKT-)mDAP-D-Ala
TABLE 3
Proposed structures of fragment ions fromMS/MS collision-induced dissociation of parental ion atm/z 808.05 (z 3)
See Fig. 7B.
Ion formed
m/z
Proposed structureCalculated Observed
[M 2H]2 489.80 489.91 (PPVPPKT-)mDAP-D-Ala
[M 2H H2O]2 498.80 498.85 (PPVPPKT-)mDAP-D-Ala
[M 2H]2 554.36 554.39 D-Glu- (PPVPPKT-)mDAP-D-Ala
[M 2H H2O]2 563.37 563.27 D-Glu- (PPVPPKT-)mDAP-D-Ala
[M H] 638.28 638.20 YPYDV
[M H] 685.41 685.33 (PPKT-)mDAP-D-Ala
[M H H2O] 703.42 703.22 (PPKT-)mDAP-D-Ala
[M 3H H2O]3 765.05 765.13 (YPYDVPDYAVNPPVPPKT-)mDAP-D-Ala
[M 3H]3 772.38 772.90 D-Glu- (YPYDVPDYAVNPPVPPKT-)mDAP
[M 3H H2O]3 778.38 778.51 D-Glu- (YPYDVPDYAVNPPVPPKT-)mDAP
[M H H2O] 832.46 832.41 D-Glu- (PPKT-)mDAP-D-Ala
[M H] 850.36 850.21 YPYDVPD
[M H H2O] 899.54 899.35 (PVPPKT-)mDAP-D-Ala
[M H H2O] 996.59 996.27 (PPVPPKT-)mDAP-D-Ala
[M H] 1013.43 1013.26 YPYDVPDY
[M H H2O] 1028.58 1028.40 D-Glu-mDAP- (PVPPKT-)D-Ala
[M H] 1084.46 1084.29 YPYDVPDYA
[M H] 1107.62 1107.29 D-Glu- (PPVPPKT-)mDAP-D-Ala
[M H H2O] 1125.63 1125.37 D-Glu- (PPVPPKT-)mDAP-D-Ala
[M H] 1183.53 1183.25 YPYDVPDYAV
[M H H2O] 1201.54 1201.26 YPYDVPDYAV
[M H] 1279.67 1280.43 DYAVNPPVPPKT
[M 2O] 1297.68 1297.26 DYAVNPPVPPKT
[M H H2O] 1315.58 1315.30 YPYDVPDYAVN
[M H H2O] 1608.76 1608.45 YPYDVPDYAVNPPV
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lar c-diGMP concentration by LC-MS/MS confirmed the pres-
ence of high levels of c-diGMP in the wild-type strain contain-
ing pECC12 (142.57 	 9.57 ng/mg bacterial dry weight),
whereas c-diGMP was undetectable in the strain carrying an
empty vector (Fig. 8A). Western blot analysis of subcellular
fractions revealed that expression of CD2831 was induced in
the presence of a high level of c-diGMP, as the protein could be
detected without using any expression in trans (Fig. 8B). More-
over, CD2831 was almost exclusively detected in the cell wall
fraction as the two predominant polypeptides of 140 and
155 kDa, suggesting that production of the ZmpI protease
was abolished in these conditions. CD2831 could not be
detected in the supernatant or the whole cell protein extract
from the wild-type strain carrying an empty plasmid. When
pECC12 was introduced into 630 srtB, CD2831 could be
detected but was mostly found in the culture supernatant, con-
sistentwith the requirement of the sortase to anchorCD2831 to
the cell wall. To complement the srtB mutant, the srtB gene
was restored to its native locus using allelic replacement. To
distinguish the complemented strain from the wild-type strain,
the original TAA stop codon of srtB was replaced with a TAG
stop codon in the complemented srtB strain. Plasmid pECC12
was transferred into the resulting strain, srtBcomp, and wild-
type CD2831 localization was restored in this strain (Fig. 8B).
To be able to modulate more precisely the c-diGMP levels in
C. difficile, plasmid pECC17, expressing DccA under control of
the Ptet-inducible promoter, was constructed and introduced
into the wild-type strain. Expression of dccA was then induced
by a range of ATc concentrations, and CD2831 levels were
determined by immunoblotting (Fig. 8C). As expected, CD2831
levels observed were directly dependent on the dose of ATc
added.Only faint bands could be observed upon inductionwith
5 ng/ml ATc, and strong bands were present upon induction
with 25 or 100 ng/ml ATc. Furthermore, when cultures were
induced with 12.5 ng/ml ATc or below, CD2831 was found
exclusively in the supernatant fraction and at a size suggesting
its cleavage by ZmpI. In contrast, upon induction with 100
ng/ml ATc, a large proportion of CD2831 is found at a higher
mass in the whole cell fraction suggesting that the c-diGMP
levels are sufficient to strongly deplete expression of ZmpI. An
intermediate state was also observed when strain was induced
with 25 ng/mlATc,withCD2831 foundboth in the supernatant
and the whole cell lysate fractions. These results indicate that
theZmpI-mediated switch from surface exposure of CD2831 to
its release into the extracellular medium release is tightly con-
trolled because a threshold c-diGMP concentration appears to
be required to activate or repress the ZmpI expression.
Immunofluorescence microscopy analysis was performed to
detect CD2831. In the wild-type strain carrying pECC12 (con-
stitutive expression of dccA) or pECC17 and grown in the pres-
ence of 100 ng/ml ATc (inducible expression of dccA), fluores-
cence was not detected (data not shown). Phase contrast
TABLE 4
Proposed structures of fragment ions from MS/MS collision-induced
dissociation of parental ion atm/z 778.38 (z 3)
See Fig. 7C.
Ion formed
m/z
Proposed structureCalculated Observed
[M 2H]2 454.28 454.31 (PPVPPKT-)mDAP
[M 2H]2 518.84 518.74 D-Glu- (PPVPPKT-)mDAP
[M H] 614.37 614.21 (PPKT-)mDAP
[M H] 638.28 638.11 YPYDV
[M H] 743.41 743.26 D-Glu- (PPKT-)mDAP
[M H] 810.49 810.27 (PVPPKT-)mDAP
[M H] 850.36 850.30 YPYDVPD
[M H] 907.54 907.41 (PPVPPKT-)mDAP
[M H] 939.53 939.33 D-Glu- (PVPPKT-)mDAP
[M H] 1013.43 1013.18 YPYDVPDY
[M H] 1036.59 1036.32 D-Glu- (PPVPPKT-)mDAP
[M H] 1084.46 1084.28 YPYDVPDYA
[M H] 1183.53 1183.25 YPYDVPDYAV
[M H] 1279.67 1279.30 DYAVNPPVPPKT
[M H] 1297.57 1297.21 YPYDVPDYAVN
[M H] 1590.49 1590.35 YPYDVPDYAVNPPV
TABLE 5
Proposed structures of fragment ions from MS/MS collision-induced
dissociation of parental ion atm/z 797.39 (z 3)
See Fig. 7D.
Ion formed
m/z
Proposed structureCalculated Observed
[M 2H]2 482.78 482.80 (PPVPPKT-)mDAP-Gly
[M 2H]2 547.30 547.22 D-Glu- (PPVPPKT-)mDAP-Gly
[M H] 638.28 638.18 YPYDV
[M H] 671.39 671.24 (PPKT-)mDAP-Gly
[M 3H]3 754.38 754.47 (YPYDVPDYAVNPPVPPKT-)
mDAP-Gly
[M H] 850.36 850.16 YPYDVPD
[M H] 867.51 867.47 (PVPPKT-)mDAP-Gly
[M H] 964.56 964.40 (PPVPPKT-)mDAP-Gly
[M H] 996.55 996.32 D-Glu- (PVPPKT-)mDAP-Gly
[M H] 1013.43 1013.32 YPYDVPDY
[M H] 1084.46 1084.23 YPYDVPDYA
[M H] 1093.61 1093.34 D-Glu- (PPVPPKT-)mDAP-Gly
[M H] 1183.53 1183.29 YPYDVPDYAV
[M H] 1279.67 1279.42 DYAVNPPVPPKT
[M H] 1297.57 1297.28 YPYDVPDYAVN
[M H] 1590.75 1590.45 YPYDVPDYAVNPPV
TABLE 6
Proposed structures of fragment ions fromMS/MS collision-induced dissociation of parental ion atm/z 902.44 (z 3)
See Fig. 7E.
Ion formed
m/z
Proposed structureCalculated Observed
[M 2H]2 575.85 575.86 mDAP- (PPVPPKT-)mDAP-D-Ala
[M 2H]2 640.37 640.39 D-Glu-mDAP- (PPVPPKT-)mDAP-D-Ala
[M 3H]3 816.42 816.86 mDAP- (YPYDVPDYAVNPPVPPKT-)mDAP-D-Ala
[M 3H]3 859.43 859.63 (D-Glu-(YPYDVPDYAVNPPVPPKT-)mDAP)-mDAP-D-Ala
[M 3H]3 872.76 873.04 D-Glu- (D-Glu- (YPYDVPDYAVNPPVPPKT-)mDAP)-mDAP
[M 2H]2 970.01 970.16 (D-Glu-(PDYAVNPPVPPKT-)mDAP)-mDAP-D-Ala
M H 1084.46 1084.21 YPYDVPDYA
[M 2H]2 1158.08 1158.16 D-Glu- (YPYDVPDYAVNPPVPPKT-)mDAP
[M H] 1183.53 1183.41 YPYDVPDYAV
[M H] 1297.57 1297.37 YPYDVPDYAVN
[M H] 1590.75 1590.64 YPYDVPDYAVNPPV
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microscopy revealed that cells carrying pECC12 grew as chains
compared with the wild-type strain carrying an empty vector
(Fig. 9A). These chains contained incomplete cell septa as visu-
alized by staining with MitoTracker Green, suggesting that
increased intracellular levels of c-diGMP result in aberrant cell
division. Chains of cells were also observed in the strain carry-
ing pECC17 upon inductionwith 100 ng/mlATc, but to amuch
lesser extent (Fig. 9B). Indeed, in the strain carrying pECC17,
chain length was found to correlate to the inducer concentra-
tion. Thus in C. difficile 630, formation of long chains of cells is
likely the direct consequence of the elevation of c-diGMP lev-
els. The absence of CD2831 immunolabeling at the surface of
cells expressing high levels of c-diGMP might be related to the
formation of chains or to insufficient levels of surface-localized
CD2831. To explore this second hypothesis, the levels of
CD2831 in strains 630 (pECC12) and 630 zmp1 (pJKP041)
were compared. The levels of CD2831 were extremely low in
630 (pECC12) compared with 630 zmp1 (pJKP041), after
induction with ATc, and were therefore probably too low to be
detected by immunofluorescence (Fig. 8D).
CD3246 Is a Second SrtB Substrate Released by the ZmpI
Protease—CD3246, identified as another putative SrtB sub-
strate, harbors a SPKTG sorting motif and is annotated as a
putative adhesin. CD3246 is not conserved across allC. difficile
lineages and is notably absent from ribotype 027 strains.
CD3246 shares similarities with CD2831. First, a c-diGMP-II
riboswitch (Cdi2_1) is present upstream of CD3246 (20). This
riboswitch controls transcription and also initiation of transla-
tion through the splicing of an allosteric self-splicing ribozyme,
located between the riboswitch and the CD3246-coding se-
quence (Fig. 10A) (35, 36). Second, CD3246 contains seven con-
secutive ZmpI cleavage sites gathered in the C-terminal
extremity of the protein (30). We therefore investigated the
subcellular localization of CD3246 to determine whether sur-
face attachment of CD3246 is controlled by the same mecha-
nismas that ofCD2831.We constructed a derivative ofCD3246
with an HA tag inserted five residues downstream of the signal
peptide. A functional RBS was also inserted upstream of the
CD3246-coding sequence because the native CD3246 RBS is
interrupted by the ribozyme (Fig. 10A). This construct was then
placed under the control of Ptet, yielding pJKP070, and intro-
duced into C. difficile 630 and srtB strains. Upon induction,
anti-HA antibodies detected the majority of the CD3246HA in
the culture supernatant of 630 (pJKP070) and a small propor-
tion in the cell wall fraction. A similar profile was obtained with
the srtB (pJKP070) strain grown in the presence of ATc, indi-
cating that the low level of cell wall associated CD3246HA is not
mediated by SrtB (Fig. 10B). Plasmid pJKP070 was then intro-
duced into the zmpI mutant. As expected, subcellular local-
ization of CD3246HAwas affected by the zmpI deletionwith the
majority of the protein now found associated to the cell wall
(Fig. 10C). Also, the apparent molecular weight of CD3246HA
was significantly larger in the absence of ZmpI, in agreement
with the proteolytic activity of ZmpI on CD3246 (Fig. 10, B and
C).
When expressed in the zmpIsrtB double mutant, the
majority of CD3246HA was secreted (Fig. 10C). The thick band
detected in the supernatant fraction had an apparentmolecular
weight slightly lower than that previously observed in the cell
wall of 630 zmpI (pJKP070), suggesting proteolytic degrada-
tion of CD3246HA when it is not associated with the cell wall.
Moreover, a faint band with a mass slightly below 116 kDa
FIGURE 8. Intracellular c-diGMP regulates the production and the subcel-
lular localization of CD2831. A, concentration of c-diGMP in the cytoplasm
of the wild-type strain (WT) carrying an empty plasmid (vector) or pECC12
(constitutively expresses DccA) (gray bar) was quantified by LC-MS/MS. Cyclic
dinucleotide concentrations are presented as nanograms of c-diGMP/mg of
bacterial dry weight, and the average and standard deviation of three values
are plotted. B, supernatant (Sn), cell wall (Cw), membrane (Mb), and cytosolic
(Cy) compartments of wild-type (WT), sortase mutant (srtB), and comple-
mented sortase (srtBcomp) strains carrying pECC12 (constitutively expresses
DccA) were analyzed by Western blotting with anti-CD2831 antibodies.
Supernatant and whole cell lysate (WL) fractions of wild-type strain carrying
an empty plasmid (vector) were also analyzed as negative controls. Proteins
were separated on 6% SDS-polyacrylamide gels. C, supernatant (Sn) and
whole cell lysate (WL) fractions of wild-type strain (WT) carrying an empty
plasmid (vector) or pECC17 (expresses DccA in the presence of ATc) and
induced with the indicated concentrations of ATc were immunoblotted with
anti-CD2831 antibodies. Proteins were separated on 6% SDS-polyacrylamide
gels. D, supernatant (Sn) and whole cell lysate (WL) fractions of zmpI mutant
strain (zmpI), carrying pJKP041 (expresses CD2831 in the presence of ATc)
and cultivated in the presence of 100 ng/ml ATc, and of wild-type strain (WT),
carrying pECC12 (constitutively expresses DccA), were immunoblotted with
anti-CD2831 antibodies.
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could be observed in the cell wall, membrane, and cytoplasm
fractions. This band might correspond to the full-length
CD3246HA protein, as the C-terminal sorting signal cannot be
cleaved in absence of SrtB. The supernatant fraction and whole
cell extract from zmpI (pJKP070) grown in the absence of
inducerwere also used as negative controls to confirm the spec-
ificity of anti-HA antibodies against CD3246HA. These data
demonstrate that SrtB is required for CD3246HA anchoring to
the cell wall and strongly suggest that the surface exposure of
the SrtB substrate CD3246 is controlled by c-diGMP levels
through its ZmpI-mediated cleavage.
Physiological Studies of the Strain Devoid of the SrtB Sortase
in Presence of Low or High Levels of c-diGMP—As our data
indicate the cell wall association of at least two SrtB substrates is
dependent on the intracellular c-diGMP levels, we investigated
the physiological role of SrtB in C. difficile in the presence of
c-diGMP. Wild-type and srtB strains carrying pECC17 or a
control vector exhibited similar growth rates in BHIS medium
regardless of induction with ATc (data not shown).
Two phenotypes have been associated with varying levels of
c-diGMP in C. difficile-biofilm formation and cell aggregation
(20, 27). However, under the conditions used, neither the wild-
type strain carrying pECC17 nor the empty vector was able to
form a significant biofilm, limiting any comparison with the
srtB mutant strains (data not shown). Differing accounts of
biofilm formation inC. difficile have been described (20, 37, 38)
as follows: specifically low or negligible levels of biofilm forma-
tion in strain 630 but higher levels in strain R20291.
Cell aggregationwas compared in liquid cultures ofwild-type
and srtB strains carrying pECC17. In agreement with the pre-
vious reports (27, 37), aggregation was observed for the wild-
type strain carrying pECC17 upon induction of dccA but not in
the wild-type strain with a control vector. Deletion of srtB had
no effect on cell aggregation, and uponATc induction, a similar
degree of aggregation was observed in 630 or the srtB strain
carrying pECC17 (data not shown). These results suggest that
SrtB does not contribute to c-diGMP-mediated aggregation.
We found that high c-diGMP levels led to the formation of
long chains of cells (see above). Phase contrast microscopy
of srtB carrying pECC12 or pECC17 grown in the presence of
ATc did not reveal an involvement of sortase, as chain length
was similar in all strains grown under identical conditions (data
not shown).
Sporulation rate was also compared between these strains in
the presence of 100 ng/ml ATc. Although the total cell count
was identical in all four strains, strains carrying pECC17 pro-
duced many more spores (6–11 spores per 105 cells) than the
strain carrying an empty vector (2.2–4.5 per 106 cells) after 24 h
FIGURE9.Elevatedc-diGMP levels induce formationof longchainof cells inC.difficile630.A,phase contrast (left and center panels) and fluorescence (right
panel) microscopy images C. difficilewild-type (WT) strain carrying an empty plasmid (vector) or pECC12 (constitutively expresses DccA). For the fluorescence
microscopy,membraneswere stainedwithMitoTrackerGreen.White triangles indicatepositionsof septa.Scalebars,20m.B,phasecontrastmicroscopyviews
of C. difficilewild-type (WT) strain carrying pECC17 (expresses DccA in the presence of ATc). Expression of DccA from pECC17 was induced with the indicated
concentrations of ATc. Black bars, 20 m.
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of growth. However, the sortase deletion had no significant
effect on the sporulation rate. After 72 h of growth, the total cell
count was similar, and sporulation rate was no longer signifi-
cantly different (1.5–2.7 spores per 102 cells) between the four
strains (Table 7). These data indicate that SrtB substrates do
not play a prominent role in sporulation or germination.
Discussion
Cyclic diGMP is a secondmessenger in bacterial systems and
a key feature in the control of critical lifestyle choices, such as
the transition between planktonic and biofilm growth. Elevated
levels of c-diGMP typically promote sessile lifestyles such as
biofilm formation; in contrast, low levels of c-diGMP are asso-
ciated with motility (39–41). C. difficile encodes 18 predicted
diguanylate cyclases and 19 predicted phosphodiesterases,
many of which have confirmed enzymatic activity (42, 43),
revealing the importance of c-diGMP signaling in this human
pathogen.
We show that c-diGMP controls surface attachment of the
putative adhesin CD2831 by controlling its expression and
mediating its cleavage and release from the cell wall by the zinc
metalloprotease ZmpI. ZmpI (CD2830) and CD2831 are
encoded on adjacent genes on the chromosome. Upstream of
zmpI is the c-diGMP-I riboswitch Cdi1_12 and upstream
ofCD2831 is the c-diGMP-II riboswitchCdi2_3. Elevated levels
of c-diGMP repress transcription of zmpI and increase tran-
scription of CD2831 (20).
We show that c-diGMP-mediated regulation directly
impacts the levels of CD2831 and presumably ZmpI proteins.
CD2831 can be detected only when cells are producing high
levels of c-diGMP, where it is found in the cell wall. In cells
producing low levels of c-diGMP, CD2831 is efficiently cleaved
and released into the supernatant by ZmpI. This suggests the
absence of ZmpI when intracellular elevated levels of c-diGMP
are high.
Themodel emerging from this finding is that at low c-diGMP
levels, a motile lifestyle is promoted. Expression of the adhesin
CD2831 is repressed, and residual low levels of surface-local-
ized protein will be shaved from the cell surface and released
into the supernatant through its cleavage by ZmpI, which is
produced under these conditions. In contrast, at elevated levels
of c-diGMP, a sessile lifestyle is promoted. Expression of
CD2831 is induced and, in the absence of ZmpI activity,
anchored at the cell surface by sortase. Thus, protease ZmpI
might play a key role in the transition from a motile to a sessile
lifestyle or additionally from a sessile to a motile lifestyle.
In C. difficile, c-diGMP has been reported to inhibit swim-
ming motility and toxin production and to promote biofilm
formation, type IV pili biogenesis, and cell aggregation (20, 27,
37, 44). Hence, the increased levels of c-diGMP promote a sed-
entary lifestyle. We envisage that in vivo, once sedentary, the
bacteria may use the adhesins CD2831 and CD3246 to interact
with extracellular matrix proteins such as collagens and/or
fibronectin to reduce the possibility of movement and to com-
mence biofilm formation. However, we were unable to detect
efficient binding of these proteins to extracellular matrix com-
ponents in vitro, suggesting perhaps that such interactions are
highly specific for substrates or conditions found in vivo.
Numerous bacterial proteases function as virulence factors
by facilitating infection of the host, and control of protease
activity by mechanisms involving c-diGMP has already been
reported. For example, in the obligatory intracellular bacterium
Ehrlichia chaffeensis, c-diGMP regulates intracellular aggrega-
tion and release from host cells through stabilization of bacte-
rial surface-exposed proteins by preventing their degradation
by endogenous proteases (45, 46). In Pseudomonas fluorescens,
a complex molecular mechanism regulating LapA proteolysis
in a c-diGMP-dependent manner has been elegantly deci-
FIGURE 10. CD3246HA is anchored to the cell wall by SrtB and is released
into theextracellularmediumthrough its cleavagebyZmpI.A, schematic
representation of chromosomal CD3246 showing its ribozyme-interrupted
RBS and of CD3246HA encoded by pJKP070 under control of the Ptet inducible
promoter and a functional RBS. The signal peptide (SP), the HA tag (HA), and
the sorting signal composed of the SPKTGmotif, the hydrophobic domain (in
gray), and the positively charged tail () are represented. The SPKTG sorting
motif is cleaved by srtB between the threonine (T) and the glycine (G) resi-
dues. B, supernatant (Sn), cell wall (CW), membrane (Mb), and cytosolic (Cy)
compartment of wild-type (WT) and sortase mutant (srtB) strains carrying
pJKP070 (expresses CD3246HA in the presence of ATc) and cultivated in the
presence of 100 ng/ml ATc (ATc) were analyzed by Western blotting with
anti-HA monoclonal antibodies. Proteins were separated on 12% SDS-poly-
acrylamide gels.C, supernatant (Sn), cell wall (CW), membrane (Mb), and cyto-
solic (Cy) compartment of zmpImutant (zmpI) and srtB/zmpI doublemutant
(srtBzmpI) strains, carrying pJKP070 (expresses CD3246HA in the presence
of ATc) and cultivated in the presence of 100 ng/ml ATc (ATc), were ana-
lyzed by Western blotting with anti-HA monoclonal antibodies. Supernatant
(Sn) andwhole cell lysate (WL) fractions ofzmpI pJKP070 strain cultivated in
the absence of ATc ([minus]ATc) were also analyzed as negative controls.
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phered.When c-diGMP is present at low levels within cells, the
N-terminal extremity of the surface-exposed adhesin LapA is
cleaved by the periplasmic cysteine protease LapG, thus releas-
ing LapA from the cell surface and leading to the loss of the
ability to form biofilm. In contrast, when c-diGMP levels are
elevated, the inner membrane-localized LapD protein seques-
ters LapG via direct protein-protein interactions, preventing
proteolytic processing of LapA. Regulation of this direct pro-
tein-protein interaction is mediated by the binding of intracel-
lular c-diGMP to LapD, which induces a conformational
change of the LapD periplasmic domain (47, 48).
In a recent study, Purcell et al. (27) successfully detected
c-diGMP inC. difficile 630 and reported its concentration to be
low compared with other bacteria. As intracellular c-diGMP
was undetectable inwild-type cells in our study, we assume that
these low levels were below the limit of detection, i.e. 0.5 ng/mg
dry weight of c-diGMP, under our experimental conditions.
Elevated c-diGMP levels have been shown to cause aggregation
of C. difficile, and scanning electron microscopy revealed the
presence of fibrous networks gathering cells in large aggregates
(27). In agreement with these data, we observed extensive cell
aggregation when c-diGMP levels were high, but additionally
we noticed the formation of long chains of cells in this condi-
tion. This phenotype is particularly marked when c-diGMP is
produced at very high levels with expression of DccA under
control of the constitutivePcwp2 promoter. Absence of this phe-
notype in the study of Purcell et al. (27)might be attributable to
the experimental conditions used by the two groups (e.g. differ-
ent systems for DccA overexpression), possibly leading to
higher c-diGMP levels in our work. Establishment of long
chains of cells is likely a direct consequence of increased
c-diGMP levels, but the mechanism involved remains to be
determined. The phenotype is likely to be associated with a
defect in cell separation andmight therefore be due to the con-
trol of the expression or activity of one or several peptidoglycan
hydrolases, as they are essential for septum formation and cell
separation (49). Interestingly, Streptococcus mutans, a strain
lacking the diguanylate cyclase Gcp and presumably producing
low levels of c-diGMP, forms extremely long chains of cells (50).
This opposite regulation highlights the fact that c-diGMP sig-
naling can play a diverse role in different bacteria. Although
beyond the scope of this study, it will be interesting to further
investigate the relation between c-diGMP and cell separation
defect in C. difficile.
We show functionality of SrtB inC. difficile and elucidate the
first anchor structure for aClostridium species. SrtB is required
for anchoring CD2831 to the cell surface. SrtB cleaves the
PPKTG motif of CD2831 between the threonine and glycine
residues and tethers the carboxyl group of threonine to the
amino group of DAP cross-bridges of peptidoglycan. srtB is the
only intact sortase gene in C. difficile, and van Leeuwen and
co-workers (30) speculated that SrtB might be the “housekeep-
ing” sortase of C. difficile with an activity similar to class A
sortases in other Gram-positive species. In agreement with this
hypothesis is the close resemblance between the (S/P)PXTG
motif recognized by C. difficile SrtB and the LPXTGmotif rec-
ognized by class A sortases. Moreover, class B sortases are gen-
erally expressed in operons containing genes encoding their
substrates, which is not the case in C. difficile (18).
Are the C. difficile SrtB substrates initially linked to the lipid
II peptidoglycan precursors or directly incorporated into the
mature peptidoglycan? In our study, immunofluorescence
microscopy revealed that high expression levels of CD2831 in a
strain lacking the protease ZmpI results in asymmetric localiza-
tion of CD2831 to one cell pole. Similar observations have been
reported for the SrtB substrate Hbp2 (SvpA) in L. monocyto-
genes (32). This species has both class A and B sortases, and a
model for the spatial cell localization of their respective sub-
strates has been proposed (14, 51). When the SrtA substrate
InlA is produced at high levels, it accumulates at the septal
region and is anchored to lipid II peptidoglycan precursors at
the newly formed pole. At the next cell division, InlA is incor-
porated at the new pole leading to the symmetrical accumula-
tion of InlA at both poles. In contrast, the SrtB substrate Hbp2
is thought to be anchored directly to themature peptidoglycan.
It therefore accumulates at old cell poles rather than at newly
formed poles, leading to an asymmetrical distribution of Hbp2
at one cell pole only.
C. difficile is atypical among Gram-positive bacteria in pro-
cessing a single active sortase. This may explain some of the
unusual features of the role of SrtB. The sortase substrates
found inC. difficile appear to have properties usually associated
with class A sortases, e.g. collagen-binding proteins, as opposed
to pili or other functional classes normally associated with sor-
tase B enzymes. However, the apparent use of assembled pep-
tidoglycan as a substrate and amino acid sequence homology
points to a class B enzyme.
Further investigation into the role of SrtB substrates CD2831
and CD3246 in the physiology of C. difficile will be required to
give a full insight into the importance of the link between two
major bacterial processes as follows: the putative virulence fac-
tor cell wall attachment catalyzed by sortase enzymes and reg-
TABLE 7
Total cell counts and sporulation rates for wild-type and srtB mutant strains carrying a control vector or pECC17 (expresses DccA in the
presence of ATc) in the presence of 100 ng/ml ATc
Values are means of results from four independent experiments.
Culture time(h) Unit
Mean value for the strain (S.D.)a
WT vector srtB vector WT pECC17 srtB pECC17
24 cfu/ml (107) 11.59 (2.6) 13.77 (1.27) 10.17 (2.35) 11.94 (3.21)
% spores (103)a 0.45 (0.44) 0.22 (0.068) 11.01 (9.75) 6.34 (5.65)
72 cfu/ml (107) 0.47 (0.31) 0.45 (0.28) 0.69 (0.62) 0.31 (0.08)
% spores (100)b 2.74 (2.76) 2.14 (1.58) 1.81 (1.91) 1.47 (0.42)
a Statistical significance for spore formation differences between strains WT vector and WT pECC17 was evaluated by a Wilcoxon test (p 0.028).
b Statistical significance for spore formation differences between strains WT vector and WT pECC17 was evaluated by a Wilcoxon test (p 0.89).
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ulation of virulence by secondmessenger c-diGMP. Such stud-
ies could include detailed kinetics of colonization of the mouse
enteric tissues using defined srtB mutants and sortase
substrates.
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Supplemental material 
Table S1. Strains, plasmids and oligonucleotides used for the present study. 
Strain, plasmid 
or primer Characteristic/description Source/construction 
 
Strains 
  
E. coli NEB5α General cloning New England Biolabs 
E. coli Rosetta Protein expression Novagen 
E. coli CA434 Conjugation donor (1) 
C. difficile strains   
630 Wild type ErmR. Virulent and 
multidrug-resistant PCR ribotype 
01 
(2) 
630Δerm Erythromycin-sensitive derivative 
of wild-type C. difficile 630 
(3) 
ΔsrtB 630 isogenic srtB deletion mutant This study 
ΔzmpI 630 isogenic zmpI deletion mutant This study 
ΔsrtB- ΔzmpI 630 isogenic double mutant with 
deletions in the aforementioned 
genes 
This study 
Ptet-srtB Insertion of the Ptet promoter 
upstream srtB of the 630 strain by 
allele exchange 
This study 
ΔsrtBcomp ΔsrtB complemented on the 
chromosome by allele exchange 
This study 
Plasmids     
pET28a E. coli expression vector. KanR Novagen 
pUC19 E. coli cloning vector. AmpR New England Biolabs 
pMTL-SC7215 E. coli-C. difficile shuttle vector for 
codA-mediated allele exchange 
mutagenesis. TmR 
(4) 
pRPF144 E. coli-C. difficile shuttle vector for 
protein expression. Pcwp2-gusA,TmR 
(5) 
pRPF185 E. coli-C. difficile shuttle vector for 
protein expression. Ptet-gusA, TmR 
(5) 
pHAS027 CD2831 (32-290)-His6 in pET28a This study 
pHAS042 His6-CD27L (1-179) in pET28a This study 
pJKP001 SrtB (27-225)-His6 in pET28a This study 
pJKP019 pUC19 with construct for srtB 
deletion 
This study 
pJKP022 pMTL-SC7215 with construct for 
srtB deletion 
This study 
pJKP029 pMTL-SC7215 with construct for 
Ptet-srtB strain creation 
This study 
pJKP041 pRPF185 derivative carrying Ptet-
CD2831 for inducible CD2831 
expression 
This study 
pJKP070 pRFP185 derivative carrying Ptet-
CD3392 with addition of a HA-tag 
encoding sequence into CD3392 
and a functional RBS upstream 
CD3392 for inducible CD3392HA 
expression 
This study 
pJKP088 pMTL-SC7215 with construct for 
zmpI deletion 
This study 
pJKP095 pJKP041 with addition of R-HA-
tag encoding sequence into 
CD2831 
This study 
pJKP096 pMTL-SC7215 with construct for 
srtB complementation 
This study 
pECC12 pRFP144 derivative carrying Pcwp2-
dccA with addition of His-tag 
encoding sequence into 3’-
extremity of dccA for constitutive 
expression of DccA. 
This study 
pECC17 pRFP185 derivative carrying Ptet-
dccA with addition of His-tag 
encoding sequence into 3’-
extremity of dccA for inducible 
expression of DccA. 
 
This study 
Primer Sequence (5’ to 3’)* Characteristics or use 
NF1614 GGGCCATGGATTCAGAATTAG
GAGAGAATAGTCAGATTC 
Amplify 5’ extremity of CD2831 
for pET28a cloning 
NF1615 GGGCTCGAGTTCTATTTTTCC
AGTAGTTTCAATATGTATTTT 
TG 
Amplify 5’ extremity of CD2831 
for pET28a cloning 
NF1968 ATATCCATGGAACTTACCAAA
TACAATCATGATACTA 
Amplify srtB deleted in the N-
terminal hydrophobic domain for 
pET28a cloning 
NF1969 TGAGCTCGAGAATCAATCTAC
CATGAATCACCAT 
Amplify srtB deleted in the N-
terminal hydrophobic domain for 
pET28a cloning 
NF2126 GATCGAGCTCGTATTTTATTT
TGGAGAAATTAATATGTTTAA
AG 
Amplify dccA with the addition of 
a C-terminal His-tag encoding 
sequence for pRFP144 or 
pRFP185 cloning. 
NF2155 GATAGAATTCCCATTTTTAAT
ATCTGTACTAACTTATATTAC 
Construction of pJKP019 for srtB 
deletion 
NF2156 GATAGGATCCGAGAAGACCT
GTCCTTAGTAC 
Construction of pJKP019 for srtB 
deletion 
NF2157 GCCAGAATGGTGATTCATGG Construction of pJKP019 for srtB 
deletion 
NF2158 CTGTAAAGTATTACTAATACT
AGTATAATGT 
Construction of pJKP019 for srtB 
deletion 
NF2169 GGATTTCACATTTGCCGTTTT
GTAAAC 
Screen for insert into pMTL-
SC7215 
NF2170 GATCTTTTCTACGGGGTCTGA
C 
Screen for insert into pMTL-
SC7215 
NF2171 GCTACATCTTATATCATATCA
TATTATTTACATC 
Screen for single and double 
crossover for srtB deletion 
NF2172 CGGTCCCTATCCGTCGC Screen for single and double 
crossover for srtB deletion 
NF2199 GATCGGATCCTTAATGGTGAT
GGTGATGGTGCTCGAGATAAT
CATTTTTATCAAATTTTTTCTT
GTTTTTC 
Amplify dccA with the addition of 
a C-terminal His-tag encoding 
sequence for pRFP144 or 
pRFP185 cloning. 
NF2214 AAACTCCTTTTTGATAATCTC
ATGACC 
Linearize pMTL-SC7215 by 
inverse PCR at the PmeI site 
NF2215 AAACTTAGGGTAACAAAAAA
CACCG 
Linearize pMTL-SC7215 by 
inverse PCR at the PmeI site 
NF2254 gttttttgttaccctaagtttGTAATATTTA
CATTGTGCAAAGTTG 
Construction of pJKP029 for 
creation of Ptet-srtB strain 
NF2257 atgtagtttaGGAGCTCAGATCTGT
TAAC 
Construction of pJKP029 for 
creation of Ptet-srtB strain 
NF2258 tgagctccTAAACTACATTTAACT
CGAGGTG 
Construction of pJKP029 for 
creation of Ptet-srtB strain 
NF2259 gattatcaaaaaggagtttCAATCTACCA
TGAATCACCATTC 
Construction of pJKP029 for 
creation of Ptet-srtB strain 
NF2260 CACTCAAAACCTTCACTCCTT
AAATC 
Screen for single and double 
crossover forcreation of Ptet-srtB 
strain 
NF2261 CAGTTTAAAATTATTGTTTTA
AACTGTGTCTG 
Screen for single and double 
crossover for creation of Ptet-srtB 
strain 
NF2266 cagaattcgTATATCTATATTACAC
TATTTTTGAATAAATTTAAAT
TTTTAG 
Construction of pJKP029 for 
creation of Ptet-srtB strain 
NF2267 atatagatataCGAATTCTGCATCAA
GCTAG 
Construction of pJKP029 for 
creation of Ptet-srtB strain 
NF2378 GATAGAGCTCAAAATGAAAG
GAGCATTAGATTTATG 
Amplify CD3392 for pRFP185 
cloning 
NF2379 GATAGGATCCTTATGATTTCT
TCATTTTACGGC 
Amplify CD3392 for pRFP185 
cloning 
NF2451 GGATCCTATAAGTTTTAATAA
AACTTTAAATAG 
Remove CD3392 coding sequence 
by inverse PCR 
NF2501 GATAGAGCTCGGAAGATTAG
ATTATAAATTATAGGTAAC 
Amplify CD2831 for pRFP185 
cloning 
NF2502 GATAGGATCCTAATTTGTATT
TTTATTTCTTCTTAATACGATA
AG 
Amplify CD2831 for pRFP185 
cloning 
NF2726 TTCCAGATTATGCTGGTCAGA Add a sequence encoding for HA 
CACCAGATGTAGA 
 
tag into the CD3246 coding 
sequence by inverse PCR 
NF2727 CATCATATGGATAATTTGATT
GTTCTTCTCCATTAAGTATTG 
Add a sequence encoding for HA 
tag into the CD3246 coding 
sequence by inverse PCR 
NF2858 AAATCTAATGCTCCTTTCATT
TTGAGC 
Remove CD3392 coding sequence 
by inverse PCR 
NF2860 gaaaggagcattagatttTTGAAAACAA
AAATTAAAAAATCAAGTATA
ATC 
Amplify CD3246 for pRFP185 
cloning 
NF2861 attaaaacttataggatccTTAATTTCTT
TTTATTTTACATTGATACGC 
Amplify CD3246 for pRFP185 
cloning 
NF2922 gttttttgttaccctaagtttCATACCATAT
TATTCCAATATGCT 
Construction of pJKP088 for zmpI 
deletion 
NF2923 atcaatattcCAAACTTATAGCTTTT
TGCAAAATTTAG 
Construction of pJKP088 for zmpI 
deletion 
NF2924 tataagtttgGAATATTGATATTAT
AGCTATTAATAATTTTTTACTT
G 
Construction of pJKP088 for zmpI 
deletion 
NF2925 gattatcaaaaaggagtttGGGGAGACT
ATACGAAATG 
Construction of pJKP088 for zmpI 
deletion 
NF2926 CCTGTGCAAAGTTGGGTTAC 
 
Screen for single and double 
crossover for zmpI deletion 
NF2956 CTTTACCAGCATTTGAAAAAT
TAGCC 
Screen for single and double 
crossover for zmpI deletion 
NF2958 CAGATTATGCTGTAAATCCAC
CAGTACCACC 
 
Add a sequence encoding for the 
R-HA tag into the CD2831 
encoding gene of pJKP041 by 
inverse PCR  
NF2959 GAACATCATATGGATACCGCA
AAGTATCATCTTTAACTTTAT
TATTTTTTTC 
Add a sequence encoding for the 
R-HA tag into the CD2831 
encoding gene of pJKP041 by 
inverse PCR 
NF2966 gttttttgttaccctaagtttCGTCTTCTTC
TCTCTGATAG 
Construction of pJKP096 for 
complementation of srtB mutant 
NF2967 tcaatctacCATGAATCACCATTCT
GGC 
Construction of pJKP096 for 
complementation of srtB mutant 
NF2968 tgattcatgGTAGATTGATTTAGAA
ACTCACAGACAC 
Construction of pJKP096 for 
complementation of srtB mutant 
NF2969 gattatcaaaaaggagtttCGGAAAGAC
CCCATGGAG 
Construction of pJKP096 for 
complementation of srtB mutant 
NF2970 GAAGGTCTTTATATAGGTTTA
AAACC 
Screen for single and double 
crossover for complementation of 
srtB mutant 
NF2971 CGGATACCTGCGACAGG 
 
Screen for single and double 
crossover for complementation of 
srtB mutant 
   
*Underlined bases indicate engineered restriction sites; lowercase bases indicate overlapping 
sequences 
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